Neurotrophic Actions of Ginsenoside Rbi, Peptide Growth Factors and Cytokines

  • Masahiro Sakanaka (Department of Anatomy and Neuroscience, Ehime University School of Medicine) ;
  • Wen, Tong-Chun (Department of Anatomy and Neuroscience, Ehime University School of Medicine) ;
  • Kohji Sato (Department of Anatomy and Neuroscience, Ehime University School of Medicine) ;
  • Zhang, Bo (Department of Anatomy and Neuroscience, Ehime University School of Medicine)
  • Published : 1998.06.01

Abstract

Ginseng root has been considered to prevent neuronal degeneration associated with brain ischemia, but experimental proof in support of this speculation is limited. Moreover, few studies have compared the neuroprotective actions of ginseng ingredients with those of peptide growth factors and cytokines isf vivo. Using a gerbil forebrain ischemia model, we demonstrated that the oral administration of red ginseng powder before an ischemic insult prevents delayed neuronal death in the hippocampal CAI field and that a neuroprotective molecule within red ginseng powder is ginsenoside Rbl. The neurotrophic effect of ginsenoside Rbl, when examined in the gerbil ischemia model and in neuronal cultures was as potent as or more potent than the effects of epidermal growth factor, ciliary neurotrophic factor, erythropoietin, prosaposin, interleukin-6 and interleukin-3. Besides the protection of hippocampal CAI neurons against brain ischemia/repercussion injuries, ginsenoside Rbl was shown to prevent place navigation disability, cortical infarction and secondary thalamic degeneration in stroke-prone spontaneous hypertensive rats with permanent occlusion of the unilateral middle cerebral artery distal to the striate branches. These findings may validate the empirical use of ginseng root for the treatment of cerebrovascular diseases

Keywords